Boehringer Ingelheim (BI) has announced positive top-line results from a late-stage study of its investigational ...

Boehringer Ingelheim’s FIBRONEER-ILD phase III study of nerandomilast to treat progressive pulmonary fibrosis meets primary endpoint: Ingelheim, Germany Wednesday, February 12, ...

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against the ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.3cY8rBmp.js ...

Lung cancer cases are increasing in people who have never smoked, especially in women, a new study by the World Health ...

Researchers from the Francis Crick Institute have found that some particularly aggressive lung cancer cells can develop their ...

Phuc Le, MD, discusses the growing prevalence of MASLD, emphasizing the need for early identification using non-invasive tools.

The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.

The Department of Trade and Industry-Bureau of Marketing and Development Promotions Office (DTI-BMDPO), in collaboration with key government agencies, proudly presents the first-ever ...